Paragraph 1 Interpretation of Schedule 7I1

In this Schedule—

• “national application” means an application for a marketing authorisation that does not involve another member State;

• “pharmaceutical product” means any veterinary medicinal product other than an immunological product;

• “simultaneous application” is an application in which, at the time an authorisation for a product is applied for, one or more additional applications are submitted for products that are identical to the first product except that—

  1. (a)

     in the case of an immunological product, they have a lesser number of antigens than the first product, but only contain antigens contained in the first product; and

  2. (b)

     in the case of a pharmaceutical product, they have different strengths of the active substance, and, in the case of an application involving more than one member State, the additional applications do not include a member State that was not included in the first application.